文献速递临床生化

HbA1c检测频率与血糖控制不佳糖尿病患者达标概率的关联

The frequency of testing for glycated haemoglobin, HbA1c, is linked to the probability of achieving target levels in patients with suboptimally controlled diabetes mellitus.
PubMed 文献 · Clin Chem Lab Med · 2018-01-01

该研究基于英国三家医院临床生化实验室记录,纳入20,690例基线HbA1c>53 mmol/mol(7%)的成人糖尿病患者,分析每年HbA1c检测次数对达标概率及HbA1c变化的影响。结果显示,一年内达到≤53 mmol/mol(7%)和≤48 mmol/mol(6.5%)目标的概率分别为0.20(95%CI 0.19-0.21)和0.10(95%CI 0.09-0.10);与每年4次检测相比,每年1次或超过4次检测与达标可能性降低相关,每年2-3次检测与4次检测的达标可能性相似。

要点

  • 血糖控制不佳的糖尿病患者一年内达标概率低,≥80%未达到常用HbA1c目标。
  • 与每年4次检测相比,每年1次或>4次检测的达标可能性更低。
  • 每年2-3次检测与每年4次检测的达标可能性相似,支持国际推荐。

核心结论

  • ≥80%的血糖控制不佳患者在1年内未达到常用HbA1c目标,医疗系统面临重大挑战。
  • 适当的监测频率重要,但每6个月检测一次与每季度检测效果相当,支持国际推荐。
  • HbA1c监测频率的重要性在糖尿病管理中未得到充分认识。

研究设计与样本

  • 研究从英国三家医院的临床生化实验室记录中提取了20,690例基线HbA1c>53 mmol/mol(7%)的成人糖尿病患者数据。
  • 采用多状态模型分析每年HbA1c检测次数对1年内达到≤53 mmol/mol(7%)和≤48 mmol/mol(6.5%)目标概率的影响。
  • 采用线性混合效应模型分析平均HbA1c的变化。

主要发现

  • 1年内达到≤53 mmol/mol(7%)目标的概率为0.20(95%CI 0.19-0.21)。
  • 1年内达到≤48 mmol/mol(6.5%)目标的概率为0.10(95%CI 0.09-0.10)。
  • 与每年4次检测相比,每年1次或超过4次检测与达到任一目标的较低可能性相关。
  • 每年2-3次检测与每年4次检测的达标可能性相似。
  • 每年1次检测的患者平均HbA1c水平高于每年4次检测的患者,平均差异为2.64 mmol/mol(0.24%),p<0.001。

临床怎么用

  • 对于血糖控制不佳的糖尿病患者,应避免每年仅检测1次HbA1c,因其与较低的达标概率和较高的平均HbA1c相关。
  • 每6个月检测一次HbA1c与每季度检测效果相当,可作为适当的监测频率。
  • 临床应充分认识HbA1c监测频率在糖尿病管理中的重要性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background We previously showed, in patients with diabetes, that >50% of monitoring tests for glycated haemoglobin (HbA1c) are outside recommended intervals and that this is linked to diabetes control. Here, we examined the effect of tests/year on achievement of commonly utilised HbA1c targets and on HbA1c changes over time. Methods Data on 20,690 adults with diabetes with a baseline HbA1c of >53 mmol/mol (7%) were extracted from Clinical Biochemistry Laboratory records at three UK hospitals. We examined the effect of HbA1c tests/year on (i) the probability of achieving targets of ≤53 mmol/mol (7%) and ≤48 mmol/mol (6.5%) in a year using multi-state modelling and (ii) the changes in mean HbA1c using a linear mixed-effects model. Results The probabilities of achieving ≤53 mmol/mol (7%) and ≤48 mmol/mol (6.5%) targets within 1 year were 0.20 (95% confidence interval: 0.19-0.21) and 0.10 (0.09-0.10), respectively. Compared with four tests/year, having one test or more than four tests/year were associated with lower likelihoods of achieving either target; two to three tests/year gave similar likelihoods to four tests/year. Mean HbA1c levels were higher in patients who had one test/year compared to those with four tests/year (mean difference: 2.64 mmol/mol [0.24%], p<0.001). Conclusions We showed that ≥80% of patients with suboptimal control are not achieving commonly recommended HbA1c targets within 1 year, highlighting the major challenge facing healthcare services. We also demonstrated that, although appropriate monitoring frequency is important, testing every 6 months is as effective as quarterly testing, supporting international recommendations. We suggest that the importance HbA1c monitoring frequency is being insufficiently recognised in diabetes management.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Duff CJ, Solis-Trapala I, Driskell OJ, et al. The frequency of testing for glycated haemoglobin, HbA1c, is linked to the probability of achieving target levels in patients with suboptimally controlled diabetes mellitus. Clin Chem Lab Med. 2018. PMID: 30281512. doi:10.1515/cclm-2018-0503

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。